삼성서울병원

Ko En

Obstetrics and Gynecology Kim, Byoung Gie M.D

Expertise
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Professional Appointments

Guest researcher National Cancer Institute, Bethesda, MD, USA

Professional Memberships

Active Member of American Association for Cancer Research
Active Member of International Gynecological Cancer Society
Member of Scientific Committee of Korean Cancer Association
Member of Scientific Committee of Korean Society of Gynecologic Oncology and Colposcopy
Active Member of Korean Society of Obstetics and Gynecology

Selected Publications

  • GYNECOL ONCOL 2021 10.1016/j.ygyno.2021.02.009 Metabolic syndrome and persistent cervical human papillomavirus infection Lee1, J; Kim, HS; Kim, K; Bae, DS; Kim, BG; Choi, CH
    View PubMed
  • LANCET ONCOL 2021 10.1016/S1470-2045(21)00098-X Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial Friedlander1, M; Moore, KN; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Lisyanskaya, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, WH; Liu, J; Mathews, C; Selle, F; Lortholary, A; Lowe, ES; Hettle, R; Flood, E; Parkhomenko, E; DiSilvestro, P
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.670214 Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix Jung1, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e31 A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) Lee1, YJ; Lim, MC; Kim, BG; Ngoi, NY; Choi, CH; Park, SY; Tan, DSP; Go, YJ; Lee, JY
    View PubMed
  • LANCET ONCOL 2020 Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer interim results of a single-arm, phase 2 trial Youn1, JW; Hur, SY; Woo, JW; Kim, YM; Lim, MC; Park, SY; Seo, SS; No, JH; Kim, BG; Lee, JK; Shin, SJ; Kim, K; Chaney, MF; Choi, YJ; Suh, YS; Park, JS; Sung, YC
    View PubMed